Your search matched 67 results
To retail behemoths, the health care realm is growing irresistible.
A new Deloitte report explores the near-future of blockchain: how seriously the world’s top executives, including many in healthcare, regard the emerging technology and how soon they might invest in it.
The Innovation Authority, the arm of the Israeli government responsible for advancing industrial R&D throughout the country, has given a multi-million-dollar grant to Zebra Medical Vision, a digital health startup.
Not your typical geotag for pharmaceutical innovation, Jackson Hole and its most prominent biologist, Paul Cox, may turn decades’ and billions of dollars’ worth of Alzheimer’s research on its head.
Where will digital therapeutics or DTx be in five years?
According to the U.S.
The elimination of CMOs at Johnson & Johnson, Uber and McDonalds highlights how marketing technologies are changing marketing at its core.
Helping modernize the clinical trials process by leaps and bounds, Janssen is undertaking new initiatives to empower research volunteers.
Last week, many Amazon Prime members received more than their usual flow of order confirmations and shipping notifications, with the retail leviathan inviting some users to “Meet PillPack, a new member of the Amazon family.”
The State Supreme Court just resolved a 10-year battle between the Cleveland Clinic and a former patient, retired U.S.
A $60 million federal program is aiming to bring the benefits of precision medicine to a diverse spread of Wisconsin communities.
Ernest Quintana knew he had long suffered from a deadly lung disease when he was rushed to the hospital, but the news of his imminent death still profoundly shocked him and his family—not because of its grimness but who delivered it: a robot.
Based on data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, one of the largest-ever clinical trials for depression, a startup called Taliaz is helping physicians pick the right antidepressant therapy off the bat.
In a telling new study, pre- and post-surgical efforts by pharmacists yielded staggering effects on patient opioid use.
Complications from drug interactions can present patients with whole new afflictions.
As the use of artificial intelligence in R&D continues to rise, Novartis takes it even further, equipping its reps with AI that suggests the perfect things to talk about with HCPs.
A landmark approval by the FDA will put the first marijuana-derived prescription drug behind pharmacy counters this fall.
Beginning with its acquisition of PillPack, Amazon’s grand entrance into healthcare continues with its partnership with J.P.
Nonprofit hospital system Partners HealthCare has unveiled a joint venture with Circulation, an on-demand rideshare service, through which Medicare patients receive free rides to their doctor’s offices in non-emergencies.
Holistic healthcare brand Otsuka Pharmaceutical has announced a promising partnership with Science 37, the trailblazing startup out of MIT that’s transforming clinical trials for everyone.
With funding from Google, Stanford, and venture capital giants Sequoia and Andreessen Horowitz, seven-year-old Zipline has already revolutionized health care in Rwanda.
With plans to enroll as many as 150,000 American senior citizens, Johnson & Johnson is collaborating with Apple on HEARTLINE, a revolutionary new study to detect atrial fibrillation (AFib), a potentially lethal condition that can lead to heart palpitations and stroke.
The growing appeal of orphan drugs to manufacturers isn’t a groundbreaking story, but a new report identifies some head-spinning facts behind the focal shift from blockbuster to rare-disease drugs.
Pharmaceutical giant Roche’s new app for people with multiple sclerosis (MS) revolutionizes how doctors care for patients with the disease.
After taking some major leaps into healthcare, Google has begun solidifying its foothold in the space by appointing Dr.
A recent proposal by the U.S.
Advantia Health, a leading-edge medical company committed to empowering women with integrated health care services, announced a new partnership with Elligo Health Research, which will offer Advantia’s clients access to a whole new realm of resources, through clinical trials.
Pfizer and Novartis have been independently developing therapies for nonalcoholic steatohepatitis (NASH), and they’re now set to join forces to yield a combination therapy for the fatty liver disease linked closely with metabolic disorders.
Health care was a central part of the discussion at this year’s Facebook F8.